Maze Therapeutics, Inc. · NASDAQ:MAZE
Dandekar Atul sold 7,500 Maze Therapeutics, Inc. shares (Form 4)
Traded Jul 29, 2026 · Filed Jul 31, 2026
On Jul 29, 2026, Dandekar Atul (CSBO) sold 7,500 Maze Therapeutics, Inc. shares at an average US$27.34 for US$205K under a trading plan, leaving 26,250 shares. Filed Jul 31, 2026 (Form 4).
- Sold
- 7,500 shares
- Price
- US$27.34 average (US$27.31 to US$27.89)
- Value
- US$205K
- Holding after
- 26,250 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CSBO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Common Stock | Option exercise | 7,500 | US$10.42 | 33,750 | Direct |
| Jul 29, 2026 | Common Stock | Sale | 7,100 | US$27.31 | 26,650 | Direct |
| Jul 29, 2026 | Common Stock | Sale | 400 | US$27.89 | 26,250 | Direct |
Source
Related
- Maze Therapeutics, Inc.
- Dandekar Atul
- Maze Therapeutics, Inc. shareholders
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Dandekar Atul · Sep 4, 2026
- Form 4 · Dandekar Atul · Sep 3, 2026
- Form 4 · Dandekar Atul · Aug 31, 2026
- Form 4 · Dandekar Atul · Jul 1, 2026
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026
- Form 4 · Coloma Jason V · Sep 4, 2026